Anti-androgens - Whole Blood and Components

Essential information

Includes

Bicalutamide (Casodex®), cyproterone acetate (Androcur®, Cyprostat®), dutasteride (Avodart®), finasteride (Propecia®, Proscar®) and flutamide (Drogenil®).

Obligatory

Must not donate if:

1. Dutasteride (Avodart®) taken in the last six months.
2. Finasteride (Propecia®, Proscar®) taken in the last four weeks.
3. Bicalutamide (Casodex®), cyproterone acetate (Androcur®, Cyprostat®) or flutamide (Drogenil®) has been taken for a malignant condition.

Discretionary

1. Donors taking cyproterone acetate for non-malignant conditions, if not affected by the Blood Safety entry, accept.
2. Donors using topical anti-androgen treatments for alopecia, including male pattern baldness, accept.

Supporting information

See if relevant

• Acne
• Blood safety
• Hair removal
• Malignancy
• Prostate problems

Additional information

Dutasteride and finasteride can cause abnormal development of the sexual organs of a male baby within the womb. As it is not possible to know if an individual donation may be transfused to a pregnant woman whose baby may be at risk, donations cannot be taken from people who may have one of these drugs in their blood. They remain in the blood even after treatment has stopped.

Cyproterone acetate (particularly in the form of Androcur®) may be used to treat male hypersexuality. In such cases a sensitive exploration of any relevant issues dealt with by the Blood safety entry should be undertaken.

Reason for change:

A discretion to accept donors using topical anti-androgens has been added.

Version details:

WB-DSG Edition 203 Release 74 (26 November 2024)